Acid sphingomyelinase as a pathological and therapeutic target in neurological disorders: focus on Alzheimer’s disease

Pharmacology, Toxicology and Pharmaceutical Science

• Neurologic Disease 100%
• Alzheimer's Disease 100%
• Sphingomyelin Phosphodiesterase 100%
• Disease 30%
• Drug Delivery System 10%
• Mouse Model 10%
• Nervous System Inflammation 10%
• Amyotrophic Lateral Sclerosis 10%
• Therapeutic Effect 10%
• Brain Ischemia 10%
• Major Depression 10%
• Ceramide 10%
• Combination Therapy 10%
• Multiple Sclerosis 10%

Neuroscience

• Neurological Disorder 100%
• Sphingomyelin Phosphodiesterase 100%
• Alzheimer's Disease 100%
• Cell Function 10%
• Blood Brain Barrier 10%
• Ceramide 10%
• Neuronal Death 10%
• Major Depressive Disorder 10%
• Multiple Sclerosis 10%
• Autophagy 10%
• Cell Membrane 10%
• Brain Ischemia 10%
• Neurogenesis 10%
• Amyotrophic Lateral Sclerosis 10%